Pebblebrook Hotel Trust (PEB) Q2 2026 Earnings Call Transcript

Pebblebrook Hotel Trust (PEB) reported Q2 same-property hotel EBITDA of $123.3M (+7.1%), topping the high end of outlook by $6.6M, driven primarily by pricing (ADR +4.7%, same-property RevPAR +6.5%) rather than occupancy (up 130 bps to 79.4%). The company raised full-year guidance, lifting same-property RevPAR growth to 4.5%–5.5% and adjusted FFO to $1.69–$1.76 per diluted share, up $0.08 at the midpoint, while keeping Q3 same-property RevPAR at 1%–3%. Capital allocation also stayed active: it sold the Chamberlain West Hollywood Hotel for $43.5M and used $26.1M of proceeds to retire $33.7M of preferred shares at a 23% discount, alongside 0.9M common share repurchases at an average $13.62.

Analysis

PEB’s leverage here is less about a one-quarter beat and more about the combination of rate mix, limited new supply, and self-help capital allocation. That is a favorable setup for hotel REITs with premium urban/resort exposure, but the second-order winner is the equity itself: if operating cash flow is rising while share count and preferred overhang are falling, per-share FFO can compound faster than property-level growth would imply. By contrast, D.C.- and convention-heavy lodging owners with weaker pricing power and less balance-sheet optionality should lag if the rate environment stays constructive.

The key risk is that this is a short-duration demand story masquerading as a structural one. Booking windows remain tight, so a government shutdown, geopolitical shock, or a softer consumer tape could hit the back half faster than the market expects; that matters more for PEB than for lower-beta lodging names because the stock is now trading on execution credibility, not just asset value. Another subtle risk is that some of the apparent outperformance is event/calendar-driven and may not repeat, while the company’s own NAV story becomes less powerful as the discount narrows.

My base case is modest near-term upside, but not a chase-the-gap move: the next 1-3 months should be driven by estimate revisions and continued July/August pace, while 6-18 months depends on whether SF/LA recovery and convention normalization actually sustain. The contrarian view is that consensus may be overestimating how much of this is cyclical vs. self-funded financial engineering; if RevPAR decelerates to the low end of guidance, the market will likely re-rate PEB back to a value trap narrative quickly. Falsifier: any material miss in Q3 RevPAR or a sudden drop in September/October booking pace would undermine the thesis.

Key Decisions for Investors

• Long PEB on pullbacks over the next 2-6 weeks; thesis is a 1-3 month estimate-upgrade cycle driven by rate mix, insurance savings, and buybacks. Exit if Q3 RevPAR trends below management’s 1%-3% guide or if booking pace rolls over.
• Pair trade: long PEB / short RLJ for the next earnings window. PEB has more direct operating leverage from premium resort and urban recovery plus stronger capital return execution; RLJ has less self-help and more normalized business-travel exposure.
• For lower-risk expression, buy a 3-6 month bullish call spread on PEB rather than common if implied vol remains contained. The trade is for upside to modestly above current pricing, with defined downside if macro headlines hit travel demand.
• Set a watch item on Washington, D.C. and San Diego convention calendars plus any federal shutdown headlines; if those deteriorate, reduce exposure to hotel REITs with urban/convention leverage first.
• If PEB closes the NAV discount materially from here, rotate incremental capital to the next laggard hotel REIT rather than adding aggressively to PEB; the easy part of the rerating may already be in the stock.